AI Article Synopsis

  • Researchers developed a prototype using ultraviolet laser-induced autofluorescence to improve the detection of nonmuscle invasive bladder cancer, especially flat and small lesions, during cystoscopy.
  • They conducted a study comparing spectroscopic results from patients with normal urothelium, papillary tumors, and flat lesions, finding significant differences in fluorescence intensity that indicate disease presence.
  • The study concluded that the new imaging method accurately identifies bladder tumors with a 100% correlation to histopathological findings, demonstrating its potential as a non-invasive diagnostic tool.

Article Abstract

Purpose: A difficulty in nonmuscle invasive bladder cancers is the diagnosis of flat and small lesions during white light cystoscopy. We assessed a prototype that measures ultraviolet laser induced autofluorescence for endoscopic detection of nonmuscle invasive bladder cancer.

Materials And Methods: We compared spectroscopic results with histological findings in 3 groups, including normal urothelium, papillary tumors and flat lesions. The developed method is based on exciting the fluorescence of molecules naturally present in tissue using ultraviolet laser pulses. The diagnostic signal was converted into the intensity ratio of the emitted light at approximately 360 and 450 nm. This ratio depends on the histopathological state of the tissue. The signal was converted into a simple color coded image, in which green indicates normal tissue and red indicates neoplasm.

Results: A total of 14 patients were included in analysis. At 360 and 450 nm excitation wavelengths the overall fluorescence intensity of bladder tumors was clearly decreased compared to that of normal urothelium regardless of tumor stage or grade. At the 308 nm excitation wavelength the shape of the tumor spectra, including carcinoma in situ, was markedly different from that of normal or nonspecific inflammatory mucosa. The correlation between red images and tumor in the specimen was 100%. No absolute intensity determinations were required since a definite diagnosis was established based on the fluorescence intensity ratio at 360 and 450 nm.

Conclusions: This feasibility study confirms the functionality of our clinical prototype for the noncontact imaging detection of nonmuscle invasive bladder cancer via an endoscope using ultraviolet excited autofluorescence measurements.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2013.01.100DOI Listing

Publication Analysis

Top Keywords

nonmuscle invasive
12
invasive bladder
12
360 450
12
ultraviolet excited
8
excited autofluorescence
8
autofluorescence measurements
8
converted simple
8
simple color
8
color coded
8
feasibility study
8

Similar Publications

Background: The role of repeat transurethral resection of bladder tumor (TURBT) for the management of nonmuscle invasive bladder carcinoma is debated, especially when initial resections include detrusor muscle. This study compares immediate second resection (additional deep biopsies in the same session) with standard restage TURBT performed 2-6 weeks post-initial TURBT to determine adequacy in detrusor muscle sampling and compare the disease rate at restage TURBT in both groups.

Material And Methods: A randomized trial was conducted at a tertiary care hospital, including patients aged ≥18 years undergoing TURBT with complete primary tumor resection.

View Article and Find Full Text PDF

Background And Objective: Research into new noninvasive diagnostic tools for bladder cancer (BCa) with superior sensitivity and specificity to cystoscopy and cytology is promising. The current study evaluated a diagnostic panel of tumor progression-related mRNAs in urine samples of NMIBC patients and controls.

Methods: This study carefully selected 129 participants, including 67 NMIBC patients, 31 hematuria patients due to nonmalignant urological disorders, and 31 healthy individuals.

View Article and Find Full Text PDF

Objective: To evaluate the efficacy, recurrence rates, and safety profile of intravesical gemcitabine plus docetaxel versus standard Bacillus Calmette-Guérin (BCG) therapy for treating naïve non-muscle-invasive bladder cancer (NMIBC), focusing on reducing recurrence and progression concerns associated with transurethral resection (TURBT).

Methods: Relevant articles were identified and appraised through a structured assessment of the literature. Databases searched included PubMed, Medline, Scopus, and Science Direct.

View Article and Find Full Text PDF

Today's controversies of gain-of-function virological research and mRNA COVID vaccination policies had an antecedent nearly a century ago in an event often referred to as "the Lübeck disaster." From April through September 1930, 77 newborn infants in Lübeck, Germany, died after receiving oral BCG immunizations tainted with active human . The tragedy threatened to end BCG immunizations.

View Article and Find Full Text PDF

Introduction: Approximately 75% of bladder cancer cases are non-muscle invasive at diagnosis. Drug development for non-muscle invasive bladder cancer (NMIBC) has historically lagged behind that of other malignancies. No treatment has demonstrated the ability to overcome drug resistance that ultimately leads to recurrence and progression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!